Skip to Navigation

Amitava Chattopadhyay


Amitava Chattopadhyay
Emerging Market Multinationals - Amitava Chattopadhyay


Ranbaxy Laboratories Limited: At the Crossroads

Ranbaxy Laboratories Limited: At the Crossroads

 

 

The case describes the challenges facing Ranbaxy, the third largest pharmaceutical company in India, which has set itself the goal of moving from the branded generic space to the greater value added branded pharmaceutical space. It has developed a one-a-day delivery system for ciprofloxacin a widely used antibiotic that is about to go off patent. Having sold the rights for the drug delivery system for markets outside India and the CIS to Bayer, the inventor of ciprofloxacin, Ranbaxy is wondering how it should market this new formulation in the India market in particular.


Teaching Objectives

The case poses several interesting questions. First, how should the one-a-day formulation of ciprofloxacin, to be called Cifran OD in India, be positioned? Ranbaxy currently markets ciprofloxacin under the name of Cifran as a branded generic in India. Should Cifran be discontinued when Cifran OD is launched? How should the Cifran OD positioning be implemented? Should the OD formulation be marketed by Ranbaxy alone or should it be co-marketed in collaboration with other local and global pharmaceutical players? The latter question facilitates an interesting discussion of when and how should one collaborate with competitors.

The case has been used for both MBA and executive audiences. It can be used in an introductory marketing course to highlight the power of good positioning. It can also be used in a course on pharmaceutical marketing or a course on how companies from emerging markets can climb the value added business ladder.



Download PDF


 

  Nov 1, 2003 | Cases




Download PDF



SHARE


 


Recent Tweets



Fri, 23 Feb @ 04:37 am

Only dishonest or stupid people would stay in a building named after #Trump, an established liar! "Trump Tower to… https://t.co/6hXm85APV0

via Hootsuite
Mon, 19 Feb @ 05:45 pm

I hope they succeed in changing the #2ndAmendment. It's sad; the hypocrisy of flying flag at half mast, but doing n… https://t.co/XKJrw82OI0

via Hootsuite
Mon, 12 Feb @ 03:25 pm

More power to you. This is the only way these platforms will take heed! "Unilever threatens to pull ads from Facebo… https://t.co/FvnCvw1Gm8

via Hootsuite
Mon, 12 Feb @ 09:52 am

Earthspired, building a brand for social impact.https://t.co/uiLD4qgwJU

via Hootsuite
Fri, 09 Feb @ 10:09 am

Growing competition for the Darwin Award! "Bangkok woman killed taking selfie on train tracks" https://t.co/mHCMhOPRr0

via Hootsuite
Sun, 21 Jan @ 10:20 am

Biggest idiots become ministers. Sadly, this embarrassment to apes is #HRD minister! hZ6R2BihRNfd93sDGWwbuN.html

via Hootsuite

  Close About Papers Cases Books Teaching Musings Media Gallery Ask Amitava